BACE inhibitor

This page shows the latest BACE inhibitor news and features for those working in and with pharma, biotech and healthcare.

Eisai to tackle dementia in new US research facility

Merck &Co has also seen failure with its BACE1 inhibitor verubecestat, which also led to the drug’s abandonment. ... However Eisai, which also has a BACE inhibitor elenbecestat in late-stage testing, has several dementia candidates in its pipeline, and

Latest news

Daily Brief: PRIME status for vaccine, NHS urged to adopt automation, Brexit vote loom

Today’s biggest pharma news is more grim tidings from the field of Alzheimer’s research – AZ and Lilly have conceded defeat on their BACE inhibitor. ... Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat.
Daily Brief: PRIME status for vaccine, NHS urged to adopt automation, Brexit votes loom

Today’s biggest pharma news is more grim tidings from the field of Alzheimer’s research – AZ and Lilly have conceded defeat on their BACE inhibitor. ... Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat.
Merck BACE inhibitor adds to litany of Alzheimer's trial failures

Merck BACE inhibitor adds to litany of Alzheimer's trial failures. Interim data shows “ virtually no chance” of clinical success for verubecestat. ... The latest disappointment comes from a phase II/III study of Merck &Co's BACE inhibitor verubecestat
Biogen rises on more positive data for Alzheimer's candidate

compounds. Last week, it partnered with AstraZeneca (AZ) on MEDI1814, an antibody against amyloid-beta 42 (Aβ42) in phase I trials, and is also working with AZ on BACE inhibitor AZD3293,
Lilly taps AstraZeneca for another anti-amyloid drug

The two companies are already working together on AZD3293, a BACE inhibitor which is designed to interrupt the formation of Aβ at an early stage in the process, and are running ... secretase inhibitor semagacestat.

More from news
Approximately 2 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Deal Watch table for September 2014

Licence and collaboration. Oral BACE inhibitor in phase I for Alzheimer's disease. ... TGR-1202 an oral P13K-delta inhibitor in phase II for haematological malignancies.
Pharma deals during September 2014

The product, an oral PK13 delta inhibitor appears to have completed phase 2 the stage when most options would expire. ... AstraZeneca and Lilly have announced a joint development and commercialisation deal for AstraZeneca's BACE inhibitor in phase I for
Eisai: Bucking the trend with R&D growth

BACE inhibitor E2609.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

New Business Director - PR: Competitive Salary and benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Director, Market Access / HEOR - North-West: Negotiable

Medical Writers: Competitive Salary and Benefits

Associate Director, Market Access & HEOR – North-West: Negotiable

Associate Director: £75, 000-90, 000

Account Director: Excellent benefits

Associate Editorial Director – Med Comms – London: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Senior Medical Writer (Remote Working): Competitive Salary Offered

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Associate Medical Director: Highly Competitive

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Project / Account Manager (Medical Education): Salary TBC

Senior Medical Writer: Competitive Salary

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Account Executive, London, Medical Communications: Excellent package

Production Manager – Healthcare Communications: DOE

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...